CN103848878B - 从蛹虫草中提取n6-(2-羟乙基)腺苷的方法及其应用 - Google Patents
从蛹虫草中提取n6-(2-羟乙基)腺苷的方法及其应用 Download PDFInfo
- Publication number
- CN103848878B CN103848878B CN201410041896.8A CN201410041896A CN103848878B CN 103848878 B CN103848878 B CN 103848878B CN 201410041896 A CN201410041896 A CN 201410041896A CN 103848878 B CN103848878 B CN 103848878B
- Authority
- CN
- China
- Prior art keywords
- adenosine
- hydroxyethyl
- link
- cordyceps militaris
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- BBOCDRLDMQHWJP-UHFFFAOYSA-N N6-(2-Hydroxyethyl)adenosine Natural products C1=NC=2C(NCCO)=NC=NC=2N1C1OC(CO)C(O)C1O BBOCDRLDMQHWJP-UHFFFAOYSA-N 0.000 title claims abstract description 60
- BBOCDRLDMQHWJP-WOUKDFQISA-N (2r,3r,4s,5r)-2-[6-(2-hydroxyethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(NCCO)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O BBOCDRLDMQHWJP-WOUKDFQISA-N 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 31
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 15
- 239000012498 ultrapure water Substances 0.000 claims abstract description 15
- 239000006228 supernatant Substances 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 12
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000004262 preparative liquid chromatography Methods 0.000 claims abstract description 7
- 238000010828 elution Methods 0.000 claims abstract description 6
- 238000010829 isocratic elution Methods 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 238000001556 precipitation Methods 0.000 claims abstract description 4
- 239000012043 crude product Substances 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000002826 coolant Substances 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 30
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 21
- 206010022437 insomnia Diseases 0.000 abstract description 20
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 7
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract description 6
- 229960005305 adenosine Drugs 0.000 abstract description 6
- 230000007958 sleep Effects 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 9
- 239000002775 capsule Substances 0.000 description 9
- 230000001624 sedative effect Effects 0.000 description 9
- 241001247821 Ziziphus Species 0.000 description 8
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 8
- 229960002336 estazolam Drugs 0.000 description 8
- 230000028527 righting reflex Effects 0.000 description 8
- 239000000932 sedative agent Substances 0.000 description 8
- 206010003084 Areflexia Diseases 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 229960004756 ethanol Drugs 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000002567 autonomic effect Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 230000004622 sleep time Effects 0.000 description 4
- BKCWMRVXLGGGBD-WOUKDFQISA-N (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-2-(2-hydroxyethyl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@]1(CCO)O[C@H](CO)[C@@H](O)[C@H]1O BKCWMRVXLGGGBD-WOUKDFQISA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000000147 hypnotic effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 229960002275 pentobarbital sodium Drugs 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002557 soporific effect Effects 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000008925 spontaneous activity Effects 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 240000007185 Albizia julibrissin Species 0.000 description 1
- 240000006739 Celastrus paniculatus Species 0.000 description 1
- 235000017186 Celastrus paniculatus Nutrition 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010048010 Withdrawal syndrome Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical class [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 1
- RMJPDRUNCDRUQC-MCDZGGTQSA-M sodium;[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound [Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)([O-])=O)[C@@H](O)[C@H]1O RMJPDRUNCDRUQC-MCDZGGTQSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041896.8A CN103848878B (zh) | 2014-01-27 | 2014-01-27 | 从蛹虫草中提取n6-(2-羟乙基)腺苷的方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041896.8A CN103848878B (zh) | 2014-01-27 | 2014-01-27 | 从蛹虫草中提取n6-(2-羟乙基)腺苷的方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103848878A CN103848878A (zh) | 2014-06-11 |
CN103848878B true CN103848878B (zh) | 2015-12-30 |
Family
ID=50857029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410041896.8A Expired - Fee Related CN103848878B (zh) | 2014-01-27 | 2014-01-27 | 从蛹虫草中提取n6-(2-羟乙基)腺苷的方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103848878B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108685935B (zh) * | 2015-05-06 | 2019-10-11 | 浙江省亚热带作物研究所 | 一种含有腺苷受体激动试剂的食品 |
CN107569612B (zh) * | 2017-09-14 | 2020-07-14 | 贵阳中医学院 | 一种改善睡眠的药物及其制备方法 |
CN111249316A (zh) * | 2020-03-11 | 2020-06-09 | 贵州贵安精准医学研究院股份有限公司 | 纯天然预防和治疗失眠的产品制备方法及应用 |
CN113480587B (zh) * | 2021-05-20 | 2024-05-03 | 湖南合健生物科技有限公司 | 一种高效提取蝉花虫草子实体中n6-(2-羟乙基)腺苷的方法 |
CN114057806B (zh) * | 2021-11-12 | 2023-04-14 | 贵州大学 | 一种分离纯化蝉拟青霉5704s菌丝体中HEA的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048770A (zh) * | 2009-11-06 | 2011-05-11 | 华中科技大学 | 一种人工培植蛹虫草子实体提取物及其制备工艺 |
CN102070690A (zh) * | 2010-11-30 | 2011-05-25 | 中国科学院大连化学物理研究所 | 一种同时制备腺苷、虫草素、n6-(2-羟乙基)腺苷化学对照品的方法 |
CN102558265A (zh) * | 2012-01-04 | 2012-07-11 | 正源堂(天津)生物科技有限公司 | 蛹虫草腺苷的提取方法 |
-
2014
- 2014-01-27 CN CN201410041896.8A patent/CN103848878B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048770A (zh) * | 2009-11-06 | 2011-05-11 | 华中科技大学 | 一种人工培植蛹虫草子实体提取物及其制备工艺 |
CN102070690A (zh) * | 2010-11-30 | 2011-05-25 | 中国科学院大连化学物理研究所 | 一种同时制备腺苷、虫草素、n6-(2-羟乙基)腺苷化学对照品的方法 |
CN102558265A (zh) * | 2012-01-04 | 2012-07-11 | 正源堂(天津)生物科技有限公司 | 蛹虫草腺苷的提取方法 |
Non-Patent Citations (6)
Title |
---|
Effect of Cordyceps militaris extract and active constituents on metabolic parameters of obesity induced by high-fat diet in C58BL/6J mice;Seon Beom Kim等;《Journal of Ethnopharmacology》;20131111;第151卷;478-484 * |
N 6-(2-HYDROXYETHYL)ADENOSINE, A BIOLOGICALLY ACTIVE COMPOUND FROM CULTURED MYCELIA OF CORDYCEPS AND ISARIA SPECIES;TSUTOMU FURUYA等;《Phytochemistry》;19831231;第22卷(第11期);2509-2512 * |
人工冬虫夏草不同部位核苷类成分分析;陆艳艳等;《食品科技》;20111231;第36卷(第4期);250-252,256 * |
提取方法对蛹虫草提取液质量的影响;吕鹏等;《山东中医杂志》;20020831;第21卷(第8期);493-494 * |
腺苷类似物的设计、合成及活性研究;王冬梅等;《药学学报》;20131231;第48卷(第6期);881-886 * |
蛹虫草子实体中N6-(2-羟乙基)-腺苷的分离纯化及抗肿瘤作用;朱丽娜等;《食用菌学报》;20131231;第20卷(第1期);62-65 * |
Also Published As
Publication number | Publication date |
---|---|
CN103848878A (zh) | 2014-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103848878B (zh) | 从蛹虫草中提取n6-(2-羟乙基)腺苷的方法及其应用 | |
CN101242850B (zh) | 文冠果的提取物和从提取物分离出的化合物的组成,功能和应用,以及它们的制备方法 | |
CN102670764B (zh) | 酸枣的活性部位及其制备方法与应用 | |
CN105017345A (zh) | 从夏枯草中同时提取四种化合物的方法及应用 | |
CN105198943B (zh) | 一种名为茶山奈苷a的酰化黄酮糖苷及其制备方法和应用 | |
CN102898322B (zh) | 一种化合物及其制法和用途 | |
CN102697770A (zh) | 九里香叶提取物及单体化合物在制备镇静催眠药物中的应用 | |
CN103342730B (zh) | 中药饿蚂蝗提取物的制备方法及其抗衰老用途 | |
CN101721434B (zh) | 一种阿里红有效组分及其制备方法和用途 | |
CN109810153B (zh) | 芳香取代葡萄糖类化合物及其药物组合物的制备方法与镇痛应用 | |
CN103751269B (zh) | 冬凌草提取物在α-葡萄糖苷酶抑制剂中的应用 | |
CN111329866A (zh) | 一种五环三萜类化合物在制备抗偏头痛药物中的应用 | |
CN102379889B (zh) | 万年蒿提取物在制备抗肝损伤药物中的应用 | |
CN105753681A (zh) | 一种胞磷胆碱钠的药物组合物及其医药用途 | |
CN104804056A (zh) | 楮头红提取物及其应用 | |
CN110680826A (zh) | 一种三萜皂苷类化合物及其盐的应用 | |
CN104523819B (zh) | 一种紫穗槐提取物及其制备方法 | |
CN110684071B (zh) | 一种三萜类化合物及其制备方法和应用 | |
CN104288142B (zh) | 木果楝素h及其类似物在制备抗抑郁症药物或食品中的用途 | |
CN109091602A (zh) | 韭菜子有效成分、提取方法及其在制备保护肝损伤药物方面的应用 | |
CN104045542B (zh) | 萘醌二聚体及其在制备抗补体药物中的用途 | |
CN102988342B (zh) | 环淫羊藿素苷元在制备抗炎、抗菌药物中的应用 | |
CN114394931B (zh) | 具有血管舒张活性的单萜生物碱及其提取方法和应用 | |
CN102100690B (zh) | 黄酮类化合物在制备抗补体药物中的用途 | |
CN101912453A (zh) | 一种具有抗炎镇痛作用的药物组合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Yaozhou Inventor after: Chen Yujiao Inventor after: Cui Jinsong Inventor after: Shu Tejun Inventor after: Chen Jianqing Inventor before: Zhang Yaozhou Inventor before: Chen Yujiao Inventor before: Cui Jinsong Inventor before: Shu Tejun Inventor before: Chen Jianqing |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150918 Address after: 300457 Tianjin economic and Technological Development Zone, West Ring Road, No. 19 TEDA Service Outsourcing Industrial Park, building 4, room three, room 4302 Applicant after: TUKE (TIANJIN) PHARMACEUTICAL TECHNOLOGY CO.,LTD. Address before: 300457 Tianjin international economic and Technological Development Zone, Binhai New Area, Tianjin Dongting Road, No. 220, Tianjin international joint Academy of biological medicine experimental building N511 Applicant before: ZHENGYUANTANG (TIANJIN) BIOTECHNOLOGY CO.,LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170413 Address after: 550025 Guizhou Province in the New District of Guizhou security comprehensive security zone Patentee after: ACADEMY OF PRECISION MEDICINE, GUIAN, GUIZHOU CO.,LTD. Address before: 300457 Tianjin economic and Technological Development Zone, West Ring Road, No. 19 TEDA Service Outsourcing Industrial Park, building 4, room three, room 4302 Patentee before: TUKE (TIANJIN) PHARMACEUTICAL TECHNOLOGY CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 550025 Guizhou Province in the New District of Guizhou security comprehensive security zone Patentee after: Guizhou Gui'an precision Medicine Co.,Ltd. Address before: 550025 Guizhou Province in the New District of Guizhou security comprehensive security zone Patentee before: ACADEMY OF PRECISION MEDICINE, GUIAN, GUIZHOU Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151230 |